COMMUNIQUÉS West-GlobeNewswire

Immune Design to Report Second Quarter 2018 Financial Results and Provide Corporate Update
25/07/2018
SEATTLE and SOUTH SAN FRANCISCO, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that it will report [...]
Apixio Launches HCC Auditor, the First AI-Powered Risk Adjustment Auditing Solution
25/07/2018
50 percent of health plan coders claim that their organization reviews less than 10 percent of charts pulled for risk adjustment coding – putting organizations at financial and compliance risk SAN MATEO, Calif., July 25 [...]
HempAmericana Provides Progress Update on CBD Oil Operations
25/07/2018
NEW YORK, July 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is proud to update shareholders and the wider investment community on the Company’s strong [...]
RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®
25/07/2018
Mytesi ® is an FDA-approved anti-diarrheal prescription drug indicated for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on anti-retroviral therapy (ART) Mytesi ® is the fourth product being [...]
Trogarzo(TM) Included in Most Recent Treatment Guidelines Issued by International Antiviral Society
25/07/2018
MONTREAL, July 25, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that Trogarzo™ (ibalizumab-uiyk) injection is now included in the most recent version of the [...]
L’International Antiviral Society ajoute Trogarzo(MC) à ses directives de traitement
25/07/2018
MONTRÉAL, 25 juill. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) est heureuse d’annoncer que Trogarzo MC (ibalizumab-uiyk) injection a été ajouté à la plus récente version des directives [...]
Changes to the Management Board of AS Olainfarm
25/07/2018
Changes to the Management Board of AS Olainfarm AS Olainfarm hereby informs about the following decisions taken by its Supervisory Council on July 24, 2018: Remove Salvis Lapins from position of Board member of AS [...]
Sonoma Pharmaceuticals Announces First Quarter FY 2019 Financial Results and Conference Call
25/07/2018
PETALUMA, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA) today announced that financial results for its fiscal year 2019 first quarter, ended June 30, 2018, will be released after [...]
IMV Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
25/07/2018
HALIFAX, Nova Scotia, July 25, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq:IMV) (TSX:IMV), a clinical stage immuno-oncology corporation, today announced that IMV Chief Executive Officer Frederic Ors will present a [...]
Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H0731 for the Treatment of Hepatitis B Virus Infection
25/07/2018
INDIANAPOLIS and SAN FRANCISCO, July 25, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ABI-H0731 [...]
Karmanos Cancer Institute hosts inaugural Prostate Cancer Awareness Game at Jimmy John’s Field, August 17
25/07/2018
Special ticket package includes $10 donation to support cancer research DETROIT, July 25, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute , in partnership with McLaren Macomb Foundation , joins the [...]
Medtronic to Provide Public Comment During CMS Committee Meeting on Volume Requirements for Transcatheter Aortic Valve Replacement (TAVR)
25/07/2018
Company to Emphasize the Importance of Evidenced-Based Quality Outcomes and Appropriate Patient Access DUBLIN and BALTIMORE - July 25, 2018 - Medtronic plc (NYSE:MDT), a global leader in heart valve therapies, will [...]
resTORbio Announces Positive Topline Results in Phase 2b Trial of RTB101
25/07/2018
-- Statistically significant and clinically meaningful 30.6% reduction in the percentage of patients with one or more laboratory-confirmed respiratory tract infections (RTIs), the primary endpoint of the trial, in the [...]
Midatech Pharma PLC: Trading Update
25/07/2018
25 July 2018 Midatech Pharma PLC (“Midatech”, “Company” or “Group”) Trading Update Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising [...]
AxoGen, Inc. to Present at Canaccord Genuity Growth Conference
25/07/2018
ALACHUA, Fla., July 25, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Peter J. Mariani, Chief [...]
miRagen Therapeutics to Report Second Quarter 2018 Financial Results and Host Conference Call on August 7, 2018
25/07/2018
BOULDER, Colo., July 25, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]
ImmuCell Announces Sale of Certain Non-Core Assets
25/07/2018
PORTLAND, Maine, July 25, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq:ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Integra LifeSciences Reports Second Quarter 2018 Financial Results
25/07/2018
Revenue Increased 29.8% to $366.2 million; Organic Revenue Increased 3.4% Reported EPS of $0.14; Adjusted EPS of $0.60 Raises Low-End of Full-Year Total Revenue and EPS Guidance Successfully Exits First Wave of Codman [...]
Natus Medical Announces Second Quarter Financial Results
25/07/2018
Reports record second quarter revenue of $130.7 million Reports second quarter GAAP loss per share of $0.08 and non-GAAP earnings per share of $0.35 Updates annual revenue and earnings guidance for 2018 PLEASANTON, [...]

Pages